What's new
DPUK collaboration wins HSJ Partnership Award
26 March 2025
Congratulations to everyone in the project team, winners of the HSJ Award for the ‘Best Pharmaceutical Partnership with the NHS’. The project was described by the organisers as 'improving accurate, early diagnosis of Alzheimer’s Disease'.
Digital test is a boost to READ-OUT biomarker study into effective ways of spotting dementia sooner
25 March 2025
People could get the right help for the diseases that can cause dementia sooner following the announcement today of a £2 million injection of funding from the government to help spot these earlier.
READ-OUT centres welcome the first volunteer patients for crucial biomarker research
28 January 2025
DPUK's READ-OUT project, part of the Blood Biomarker Challenge, is set to welcome patients to the first of 28 centres across the UK who are participating in the study.
A snapshot of 2024
19 December 2024
Facts speak for themselves. So, I am letting them speak more eloquently than I can at the end of another fruitful and satisfying year for DPUK and its amazing team.
How is Dementias Platform UK enhancing research into dementia?
Watch this introductory video about Dementias Platform UK (DPUK) and how it is bringing together the best scientific minds and global leaders in the pharmaceutical industry to find new ways of detecting, treating and preventing dementia.
Get the DPUK newsletter
Sign up to subscribe to the DPUK newsletter.
Keep up to date with all that's going on at Dementias Platform UK. There are around 4 newsletters a year, which include news about developments in our infrastructure services, studies, partnerships and collaborations.
Social Media
We're currently active on LinkedIn, X (Twitter) and BlueSky where we post about every aspect of DPUK. Most of our news is shared on these channels first including jobs, new studies, programme's milestones, information on training, seminars and conferences.
Science feature
DPUK collaboration identifies possible new target for drug repurposing in dementia
Jodi Watt, a Postdoctoral Researcher at the University of Glasgow, is part of a team involving researchers at the University of Glasgow, Cardiff University, University of Cambridge, and St George’s, University of London, who have identified a possible new drug target for repurposing in dementia. Here, they explain how the team has used research cohort data, national clinical data, and genetic data to identify this target, and why we should be excited but cautious about the findings.
The DPUK Data Portal gives researchers rapid, secure access to multimodal datasets and millions of health research records.
Our Trials Delivery Framework matches public volunteers to the right dementia studies and has over 80 clinical sites across the UK.
DPUK's Experimental Medicine Incubator accelerates and de-risks the development of new treatments for dementia.
Work with us
Would you like to increase the international visibility of your data? Try our Data Portal.
Do you need well-characterised volunteers for your early-phase trial? Use our Trials Delivery Framework.
Is there a mechanism you would like to investigate? Explore our Experimental Medicine Incubator.